Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
People At High Risk Of HIV Are Having The HIV Prevention Pill Taken From Them

Exclusive: The NHS is stopping participants in a major study into the drug Truvada from having further access to it – a move which Britain’s biggest HIV charity said would lead some to become infected.

Published
18 hours ago
From
Buzzfeed
As EU Approval Moves Closer Are Governments Prepared For PrEP?

On Friday the EU's Committee for Medicinal Products for Human Use (CHMP) announced its positive opinion on Gilead’s HIV pre-exposure prophylaxis product Truvada PrEP. But with many European governments trying to control healthcare costs, the biggest issue facing Truvada PrEP might not be approval but rather reimbursement.

Published
27 July 2016
From
Seeking Alpha
European CHMP Adopts Positive Opinion on Truvada® for Pre-Exposure Prophylaxis

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Type II variation application for once-daily Truvada® (emtricitabine 200 mg/tenofovir disoproxil 245 mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk, a strategy known as pre-exposure prophylaxis, or PrEP.

Published
22 July 2016
From
Gilead press release
HIV Drug Pricing Protest Interrupts PrEP Session at AIDS 2016

Protesters against the high cost of antiretroviral drugs joined forces and marched together today, interrupting a research presentation today at the 21st International AIDS Conference (AIDS 2016).

Published
21 July 2016
From
BETA blog
With 20 Billion Condoms and 3 Million People on PrEP, Could We Reach the UNAIDS HIV Prevention Goal in 5 Years?

Can we reduce the total number of new HIV infections that happen worldwide every year, from 2 million to 500,000—in five years?

Published
19 July 2016
From
BETA blog
How do you talk about PrEP to young Black men at risk for HIV?

Since the FDA approved Truvada to be used as pre-exposure prophylaxis (PrEP) on July 16, 2012–four years ago now–I have had the wonderful fortune to speak with doctors and healthcare … Read More →

Published
16 July 2016
From
BETA blog
Treatment Action Group: Pipeline Report 2016

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
15 July 2016
From
Treatment Action Group
HIV pill could cut infections in gay, bisexual men by a third

The rate of new HIV infections among gay and bisexual men could drop by up to a third over the next decade if enough eligible men take a drug that protects against the virus, researchers estimate.

Published
15 July 2016
From
Reuters
Judge urged to overturn NHS decision not to fund HIV prevention treatment

Court hears National Aids Trust challenge over NHS England decision to exclude PrEP drug from commissioning cycle.

Published
14 July 2016
From
The Guardian
Despite medical advances, HIV epidemic continues for gay men across the globe

Across countries and income levels, gay men continue to see disproportionately high rates of HIV infection, according to a new study from Johns Hopkins University's Bloomberg School of Public Health.

Published
11 July 2016
From
Johns Hopkins University
← First12345...69Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close